© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Nitric oxide inhibits ischemia/reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity
aDepartment of Cardiovascular Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo 113-8519, Japan
bDepartment of Biochemical Genetics, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo 113-8519, Japan
* Corresponding author. Tel.: +81-3-5803-5218; fax: +81-3-5803-0133. sadachi.cvm{at}tmd.ac.jp
Objective: Ischemia/reperfusion in the heart causes myocardial apoptosis and increase nitric oxide (NO) production. We have reported that myocardial apoptosis is related to activation of cell cycle regulatory proteins. However, the role of nitric oxide (NO) in ischemia/reperfusion-induced apoptosis is still unclear. This study was designated to elucidate novel apoptosis mechanisms induced by ischemia/reperfusion, especially the interaction between NO and cell cycle regulators. Methods and results: Neonatal cardiomyocytes from 1- or 2-day-old Wistar rats were subjected to 1-h ischemia and then to reperfusion. The rate of cardiomyocyte apoptosis increased significantly after 24 h of reperfusion as evaluated by TUNEL analysis. NO increased 1.8-fold after 15 min of reperfusion in cardiomyocytes. After 36 h of reperfusion, the apoptosis rate was greatly increased by the NO synthetase inhibitor, Nitro-L-arginine methyl ester (L-NAME), and decreased by the NO donor of S-nitroso-N-acetylpenicillamine (SNAP). Immunoblot analysis showed that the protein levels of cyclin A accumulated in a time-dependent manner in response to ischemia/reperfusion, and L-NAME inhibited this response. Ischemia/reperfusion also increased the activity of cyclin A-associated kinase, and the apoptosis was inhibited by infection of dominant-negative cdk2 adenovirus. To clarify the involvement of p21cip1/waf1 protein, which is the suppressor of cyclin A-associated kinase, we performed immunoblot analysis and examined its kinase activity. Treatment of cardiomyocytes with L-NAME suppressed the p21cip1/waf1 protein level and increased the cyclin A-associated kinase activity. The addition of SNAP showed inverse results. Conclusion: Our data indicates that NO released from cardiomyocytes under condition of ischemia/reperfusion exerts an antiapoptotic effect by modulating cyclin A-associated kinase activity via p21cip1/waf1 accumulation.
KEYWORDS Apoptosis; Ischemia; Myocytes; Nitric oxide; Reperfusion
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Yuan, J. Deng, T. Wang, C. Zhao, X. Xu, P. Wang, J. W. Voltz, M. L. Edin, X. Xiao, L. Chao, et al. Tissue Kallikrein Reverses Insulin Resistance and Attenuates Nephropathy in Diabetic Rats by Activation of Phosphatidylinositol 3-Kinase/Protein Kinase B and Adenosine 5'-Monophosphate-Activated Protein Kinase Signaling Pathways Endocrinology, May 1, 2007; 148(5): 2016 - 2026. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Shao, W.-T. Chang, K. C. Chan, K. R. Wojcik, C.-W. Hsu, C.-Q. Li, J. Li, T. Anderson, Y. Qin, L. B. Becker, et al. Hypothermia-induced cardioprotection using extended ischemia and early reperfusion cooling Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1995 - H2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fiedler, R. Feil, F. Hofmann, C. Willenbockel, H. Drexler, A. Smolenski, S. M. Lohmann, and K. C. Wollert cGMP-dependent Protein Kinase Type I Inhibits TAB1-p38 Mitogen-activated Protein Kinase Apoptosis Signaling in Cardiac Myocytes J. Biol. Chem., October 27, 2006; 281(43): 32831 - 32840. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Cuong, N. Kim, J. B. Youm, H. Joo, M. Warda, J.-W. Lee, W. S. Park, T. Kim, S. Kang, H. Kim, et al. Nitric oxide-cGMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K+ channels in rat hearts Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1808 - H1817. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Manukhina, H. F. Downey, and R. T. Mallet Role of nitric oxide in cardiovascular adaptation to intermittent hypoxia. Experimental Biology and Medicine, April 1, 2006; 231(4): 343 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Cagli, C. Bagci, M. Gulec, B. Cengiz, O. Akyol, I. Sari, S. Cavdar, S. Pence, and H. Dinckan In Vivo Effects of Caffeic Acid Phenethyl Ester on Myocardial Ischemia-Reperfusion Injury and Apoptotic Changes in Rats Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 440 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schleicher, F. Brundin, S. Gross, W. Muller-Esterl, and S. Oess Cell Cycle-Regulated Inactivation of Endothelial NO Synthase through NOSIP-Dependent Targeting to the Cytoskeleton Mol. Cell. Biol., September 15, 2005; 25(18): 8251 - 8258. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Futamatsu, J.-i. Suzuki, S. Mizuno, N. Koga, S. Adachi, H. Kosuge, Y. Maejima, K. Hirao, T. Nakamura, and M. Isobe Hepatocyte Growth Factor Ameliorates the Progression of Experimental Autoimmune Myocarditis: A Potential Role for Induction of T Helper 2 Cytokines Circ. Res., April 29, 2005; 96(8): 823 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ono, Y. Sawa, M. Ryugo, A. N. Alechine, S. Shimizu, R. Sugioka, Y. Tsujimoto, and H. Matsuda BH4 peptide derivative from Bcl-xL attenuates ischemia/reperfusion injury thorough anti-apoptotic mechanism in rat hearts Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 117 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Onai, J.-i. Suzuki, T. Kakuta, Y. Maejima, G. Haraguchi, H. Fukasawa, S. Muto, A. Itai, and M. Isobe Inhibition of I{kappa}B phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury Cardiovasc Res, July 1, 2004; 63(1): 51 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Aoudjit and J. Sevigny P21Waf1/Cip1 in endothelial cell survival Cardiovasc Res, March 1, 2004; 61(4): 648 - 650. [Full Text] [PDF] |
||||
![]() |
C. Pignatti and C. Stefanelli Ischemia/reperfusion-induced apoptosis: connecting nitric oxide and cell cycle regulators Cardiovasc Res, August 1, 2003; 59(2): 268 - 270. [Full Text] [PDF] |
||||








